Given the current underperformance of European banks and the downsizing of IBDs (e.g. DB, Barclays), how is advisory (M&A and equity/ debt underwriting) going to develop in the future?
Are independent advisors taking over?
(This applies in particular to European banks)
| +196 | Evercore > Goldman and I don’t think it’s particularly close anymore | 75 | 1h |
| +160 | Article: Why UBS's Asian M&A bankers are thriving and UBS's American M&A bankers are not | 18 | 21h |
| +135 | Think Twice before Recruiting for HOUSTON IB!! | 60 | 16h |
| +74 | I hate Wells Fargo | 20 | 23h |
| +57 | No return offer - feeling like a failure is an understatement | 24 | 23h |
| +50 | How cooked am I as an incoming WF IB SA 2027? | 17 | 2d |
| +48 | WF Return offers | 32 | 14h |
| +41 | Should I go back into a junior IBD role for comp? | 19 | 17h |
| +39 | Mid-Level UBS Departure for another BB (Grass Isn’t Greener…) | 31 | 15h |
| +38 | No RO and Dark Thoughts | 11 | 2d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Personally I think industry wise I think definitely EBs (+ european boutiques like Robey Warshaw) + US BB will take over more market share that DB/UBS lose.
Not sure how specific firms will do but if I had to guess DB will always have a presence (german pride + solid historic performance) in EMEA especially with European lev fin although with the piss poor balance sheet I think it'll take at least 2-3 more years of restructuring before they think about any growth. CS is still a strong player in IB esp EMEA and the CEO just said they won't be downsizing anymore (albeit I believe he was referring to S&T more so). I think Barclays wants to continue its investment into IB and grow the group, have seen couple of hires within Chemicals/Industrials/HC in the US so I'd reckon they'd be continuing that for Europe (not sure which groups in particular though just making a guess). UBS I have no idea with all the focus on PWM/AM I'm surprised they're still decently strong with IB.
I think couple 3rd tier firms like BNP/Soc Gen/HSBC will be interesting. I think in the next couple of years some will completely be even more irrelevant (Soc Gen) whereas others (HSBC) have a chance maybe to gain a bit more market share.
Just my opinion based on what I'm hearing from buddies of mine in different firms and reading the news. Then again based in the US so I could be 100% wrong.
Qui impedit corrupti blanditiis natus blanditiis. Ipsa a dignissimos incidunt sunt. Nostrum officia modi necessitatibus.
Magni laboriosam id reprehenderit ipsa quia quis est. Sit necessitatibus voluptatibus optio. Illum necessitatibus sit culpa consequuntur necessitatibus saepe impedit earum. Voluptatem reprehenderit assumenda quae. Aut dignissimos sit temporibus fugiat ipsum inventore voluptates laboriosam.
Occaecati ut praesentium quia omnis laborum dolorum accusantium. Aut non sunt et esse sit dolor laborum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...